News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Agenus (AGEN) Auspex (ASPX) CRISPR Therapeutics (CRSP) Telaprevir Valeant Pharmaceuticals International (VRX) Dendreon (DNDN) Sanofi (SNA) Alder Biopharmaceuticals (ALDR) Vitae Pharmaceuticals (VTAE) CompuGen (CGEN) Exelixis (EXEL) Herceptin GUARDIAN HEALTH Intercept (ICPT) Genentech Xoma (XOMA) Ariad (ARIA) ADVENTRIX (ANX) Revlimid (lenolidamide) Theravance (THRX) Endometrial Cancer SYNTA (SNTA) JUNO (JUNO) Array Pharmaceuticals (ARRY) Idenix (IDIX) Ocular Therapeutix (OCUL) Pluristem (PSTI) VANDA (VNDA) Vertex (VRTX) Gilead (GILD) KITE (KITE) ISIS (ISIS) NEKTAR (NKTR)) Ziofpharm (ZIOP) Merck (MRK) AGOS (ARGS) RenenxBio (RGNX) Mirati Therapeutics (MRTX) Human Longevity (HLI) Multiple Myeloma Theravance Bio Pharma (TBPH) Anadys (ANDS) Jazz Pharmaceuticals (JAZZ) Galena (GALE) Tysabri Biocryst (BCRX) Intrexon (XON) Intermune (ITMN) SERES THERAPEUTICS (MCRB) Zerenex Cytokinetics (CYTK) Spike Therapeutics (ONCE) Dynavax (DVAX) Benlysta (belimumab) Advaxis (ADXS) PTC Therapeutics (PTCT) galapagos (GLPG) Human Genome Sciences (HGSI) Bristol-Myers Squibb (BMY) Roche (RHHBY) Ridaforolimus Adaptimmune (ADAP) C4 Therapeutics ABBVIE (ABBV) AERIE PHARMACEUTICALS Onyx (ONXX) ARGOS (ARGS) NANTKWEST (NK) Velcade (bortezomib) SUNESIS PHARMACEUTICALS (SNSS) REGULUS (RGLS) Biogen Idec (BIIB) MODERNA Aimmune Therapeutics (AIMT) Global Cell Therapeutics (GBT) NOVOCURE (NVCR) Elan (ELN) Seattle Genetics (SGEN) Micromet (MITI) Inovio (INO) Prolor Biotech (PBTH) ImmunoGen (IMGN) Ionis (IONS) Agenus (AGEN ACADIA (ACAD) Abbott Laboratories (ABT) Alnylam (ALNY) Anacor (ANAC) Illumina (ILMN) Incyte (INCY) INNOVIVA (INVA) Sanofi (SNY) Regeneron (REGN) Sanofi-Aventis (SAN) KERYX (KERX) ZALTRAP™ Amgen (AMGN) OSI (OSIP) IDERA (IDRA) HALOZYME (HALO) AstraZeneca (AZN) Rapamune Editas (EDIT) Roche (ROCHE) Bellicum (BLCM) Sequenom (SQNM) ARCA (ABIO) GlaxoSmithKline (GSK) TOKAI (TKAOI) Trastuzumab-DM1 Prosensa (RNA) BIOMARIN (BMRN) Sarepta (SRPT) Sangamo (SGMO)